Optimal Medical Therapy for HFrEF (2024) Unknown Author

Description

Analysis of guideline-directed optimal medical therapy (OMT) for Heart Failure with reduced Ejection Fraction (HFrEF). The material reviews key drug classes, including ACEi/ARB/ARNI, beta-blockers, MRA, and SGLT2i, detailed pharmacology (e.g., Neprilysin inhibition), and crucial clinical trial data like PARADIGM-HF.